The perils of portliness - Causes and consequences of visceral adiposity

被引:500
作者
Montagne, CT
O'Rahilly, S
机构
[1] AstraZeneca, Cardiovasc & Gastrointestinal Discovery Res Dept, Macclesfield SK10 4TG, Cheshire, England
[2] Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 2QQ, England
[3] Univ Cambridge, Addenbrookes Hosp, Dept Clin Biochem, Cambridge CB2 2QQ, England
关键词
D O I
10.2337/diabetes.49.6.883
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Although an individual's total fat mass predicts morbidities such as coronary artery disease and diabetes, the anatomical distribution of adipose tissue is a strong and independent predictor of such adverse health outcomes. Thus, obese individuals with most of their fat stored in visceral adipose depots generally suffer greater adverse metabolic consequences than similarly overweight subjects with fat stored predominantly in subcutaneous sites. A fuller understanding of the biology of central obesity will require information regarding the genetic and environmental determinants of human fat topography and of the molecular mechanisms linking visceral adiposity to degenerative metabolic and vascular disease. Here we attempt to summarize the growing body of data relevant to these key areas and, in particular, to illustrate how recent advances in adipocyte biology are providing the basis for new pathophysiological insights.
引用
收藏
页码:883 / 888
页数:6
相关论文
共 74 条
  • [1] Activators of peroxisome proliferator-activated receptor γ have depot-specific effects on human preadipocyte differentiation
    Adams, M
    Montague, CT
    Prins, JB
    Holder, JC
    Smith, SA
    Sanders, L
    Digby, JE
    Sewter, CP
    Lazar, MA
    Chatterjee, VKK
    O'Rahilly, S
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (12) : 3149 - 3153
  • [2] Systemic resistance to the antilipolytic effect of insulin in black and white women with visceral obesity
    Albu, JB
    Curi, M
    Shur, M
    Murphy, L
    Matthews, DE
    Pi-Sunyer, FX
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 1999, 277 (03): : E551 - E560
  • [3] Production of plasminogen activator inhibitor 1 by human adipose tissue - Possible link between visceral fat accumulation and vascular disease
    Alessi, MC
    Peiretti, F
    Morange, P
    Henry, M
    Nalbone, G
    JuhanVague, I
    [J]. DIABETES, 1997, 46 (05) : 860 - 867
  • [4] BETA-ADRENOCEPTOR EXPRESSION IN HUMAN FAT-CELLS FROM DIFFERENT REGIONS
    ARNER, P
    HELLSTROM, L
    WAHRENBERG, H
    BRONNEGARD, M
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1990, 86 (05) : 1595 - 1600
  • [5] Surgical removal of visceral fat reverses hepatic insulin resistance
    Barzilai, N
    She, L
    Liu, BQ
    Vuguin, P
    Cohen, P
    Wang, JL
    Rossetti, L
    [J]. DIABETES, 1999, 48 (01) : 94 - 98
  • [6] Leptin concentration in women is influenced by regional distribution of adipose tissue
    Bennett, FI
    McFarlaneAnderson, N
    Wilks, R
    Luke, A
    Cooper, RS
    Forrester, TE
    [J]. AMERICAN JOURNAL OF CLINICAL NUTRITION, 1997, 66 (06) : 1340 - 1344
  • [7] DIFFERENCES AT THE RECEPTOR AND POSTRECEPTOR LEVELS BETWEEN HUMAN OMENTAL AND SUBCUTANEOUS ADIPOSE-TISSUE IN THE ACTION OF INSULIN ON LIPOLYSIS
    BOLINDER, J
    KAGER, L
    OSTMAN, J
    ARNER, P
    [J]. DIABETES, 1983, 32 (02) : 117 - 123
  • [8] Bouchard C, 1996, INT J OBESITY, V20, P420
  • [9] GENETIC AND NONGENETIC DETERMINANTS OF REGIONAL FAT DISTRIBUTION
    BOUCHARD, C
    DESPRES, JP
    MAURIEGE, P
    [J]. ENDOCRINE REVIEWS, 1993, 14 (01) : 72 - 93
  • [10] A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance
    Bruning, JC
    Michael, MD
    Winnay, JN
    Hayashi, T
    Horsch, D
    Accili, D
    Goodyear, LJ
    Kahn, CR
    [J]. MOLECULAR CELL, 1998, 2 (05) : 559 - 569